Scholarly Journal Articles

o   DuPont RF, Lieberman JA: Young brains on drugs. Science [Editorial] 2014; 344(6184):557

o   Lieberman JA, Dixon LB, Goldman HH: Early detection and intervention in schizophrenia: a new therapeutic model. JAMA 2013; 310(7):689-690.

o    Miyamoto S, Miyake N, Jarskog LF, Fleischhacker WW, Lieberman JA: Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. [Feature Review] Mol Psychiatry 2012; 12:1206-1227.

o   Lieberman JA, Stroup TS: The NIMH-CATIE schizophrenia study: what did we learn? Am J Psychiatry 2011; 168(8):770-775

o   Merrill DB, Girgis RR, Bickford LC, Vorel SR, Lieberman JA: Teaching trainees to negotiate research collaborations with industry: a mentorship model. Am J Psychiatry 2010; 167(4):381-386.

o   Lieberman JA, Drake RE, Sederer LI, Belger A, Keefe R, Perkins D, Stroup TS: Science and recovery in schizophrenia. Psychiatric Services 2008; 59:487-496

o   Corcoran C, Lieberman JA: The impossible dream: can psychiatry prevent psychosis? Early Intervention in Psychiatry 2007; 1:219-221

o   Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005; 353(12):1209-1223.

o   Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M: Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 2005; 62(4):361-370

o   Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J: The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology and therapeutic approaches. Biological Psychiatry 2001; 50(11):884-897.

o    Lieberman JA: Starting a career in psychiatric research: The Lessons of Experience. Academic Psychiatry 2001; 25:28-30

o   Lieberman JA, Fenton WS: Delayed detection of psychosis: Causes, consequences, and effect on public health. American Journal of Psychiatry 2000; 157:1727-1734

o   Lieberman JA: Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biological Psychiatry 1999; 46(6):729-739

o   Robinson DG, Woerner MG, Alvir JMa.J, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 1999; 56(3):241-247

o   Robinson DG, Woerner MG, Alvir JMa.J, Geisler S. Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry 1999; 156(4):544-549

o   Lieberman JA, Rush AJ. Redefining the role of psychiatry in medicine. American Journal of Psychiatry 1996; 153(11):1388-1397

o   Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA: Clozapine induced agranulocytosis: Incidence and risk factors in the United States. New England Journal of Medicine 1993; 329:162-167

o   Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DI, Geisler SH, Szymanski SR: Duration of psychosis and outcome in first episode schizophrenia. American Journal of Psychiatry 1992; 149:1183-1188

o   Lieberman JA, Yunis J, Egea E, Kane JM, Yunis EJ: HLA-B38, DR4, DQW3 and Clozapine Induced Agranulocytosis in Jewish Patients with Schizophrenia. Archives of General Psychiatry 1990; 47:945-948

o   Lieberman JA, Ehrhardt AA, Simpson HB, Arbuckle MR, Fyer AJ, Essock SM. Eliminating the Glass Ceiling in Academic Psychiatry. Acad Psychiatry. 2017 Nov 6. doi: 10.1007/s40596-017-0810-5

o   Ballon JS, Pajvani UB, Mayer LE, Freyberg Z, Freyberg R, Contreras I, Rosenbaum M, Leibel RL, Lieberman JA. Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo. J Psychopharmacol. 2018 Feb 1:269881118754708. doi: 10.1177/0269881118754708.